Stay updated on Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates about a terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.6%
    Check dated 2026-10-25T13:27:53.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:58:19.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The trial’s record history now includes a version submitted October 1, 2026, documenting a Study Status update. The record’s latest posted-update date is October 5, 2026.
    Difference
    0.4%
    Check dated 2026-10-11T14:43:27.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the study record history, replacing the previous v3.6.6 entry. This updates the historical versioning of the record without changing the study details.
    Difference
    0.1%
    Check dated 2026-09-20T20:41:59.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 appears in the Record History, replacing the previous v3.6.5, signaling a minor update to the page’s release notes.
    Difference
    0.1%
    Check dated 2026-08-30T21:39:26.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    A newer revision entry, v3.6.5, was added to the study record history, representing an update to the record. The previous revision, v3.6.4, was removed from the history list.
    Difference
    0.1%
    Check dated 2026-08-09T09:18:13.000Z thumbnail image

Stay in the know with updates to Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.